Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 301–350 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
BRVEBraveheart Bio, Inc. Healthcare Nov 10 Sep '26 $0.0M — −$26.0M — −$0.51 — — — $1.3B
ANROAlto Neuroscience, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$25.0M n/m −$0.54 n/m — — $999M
IMTXImmatics N.V. Healthcare Nov 10 Sep '26 $7.8M +40.0% — n/m −$0.58 n/m — — $941M
KURAKura Oncology, Inc. Healthcare Nov 10 Sep '26 $23.0M +9.5% −$70.0M n/m −$0.78 n/m -326.9% +58.6 pp $688M
OLMAOlema Oncology, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$74.0M n/m −$0.73 n/m — — $633M
QUITAchieve Life Sciences, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$12.0M n/m −$0.11 n/m — — $630M
ABUSArbutus Biopharma Corporation Healthcare Nov 10 Sep '26 $0.0M n/m $59.0M n/m $0.30 n/m — — $621M
CGEMCullinan Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$49.0M n/m −$0.76 n/m — — $602M
OBIOOrchestra BioMed Holdings, Inc. Healthcare Nov 10 Sep '26 $0.0M −100.0% −$19.0M n/m −$0.30 n/m — — $549M
AVRAnteris Technologies Global Corp. Healthcare Nov 10 Sep '26 $1.0M n/m −$27.0M n/m −$0.28 n/m — — $519M
CAPRCapricor Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$43.0M n/m −$0.73 n/m — — $487M
CARLCarlsmed, Inc. Healthcare Nov 10 Sep '26 $22.0M +69.2% −$12.0M n/m −$0.45 n/m -58.9% +10.2 pp $486M
EPRXEupraxia Pharmaceuticals Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$15.0M n/m −$0.23 n/m — — $445M
OVIDOvid Therapeutics Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$21.0M n/m −$0.10 n/m — — $419M
MASS908 Devices Inc. Healthcare Nov 10 Sep '26 $19.0M +35.7% −$5.0M n/m −$0.11 n/m -30.5% +8.9 pp $390M
IRDOpus Genetics, Inc. Healthcare Nov 10 Sep '26 $1.0M n/m −$46.0M n/m −$0.46 n/m — — $337M
PEPGPepGen Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$19.0M n/m −$0.28 n/m — — $269M
PLXProtalix BioTherapeutics, Inc. (DE) Healthcare Nov 10 Sep '26 $22.0M +22.2% $4.0M +100.0% $0.05 +66.7% 18.5% +6.5 pp $243M
IKTInhibikase Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$20.0M n/m −$0.10 n/m — — $194M
ELMDElectromed, Inc. Healthcare Nov 10 Sep '26 $19.0M +11.8% $3.0M +50.0% $0.32 +28.0% 18.7% +2.9 pp $189M
PALIPalisade Bio, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$15.0M n/m −$0.07 n/m — — $181M
BBOTBridgeBio Oncology Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$34.0M n/m −$0.43 n/m — — $156M
KRMDKORU Medical Systems, Inc. Healthcare Nov 10 Sep '26 $12.0M +20.0% $0.0M n/m $0.00 n/m 1.6% +10.0 pp $151M
TLSITriSalus Life Sciences, Inc. Healthcare Nov 10 Sep '26 $13.0M +8.3% −$9.0M n/m −$0.15 n/m -59.9% +18.1 pp $142M
HUMAHumacyte, Inc. Healthcare Nov 10 Sep '26 $1.0M 0.0% −$16.0M n/m −$0.06 n/m — — $139M
SIONSionna Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$32.0M n/m −$0.72 n/m — — $139M
MXCTMaxCyte, Inc. Healthcare Nov 10 Sep '26 $10.0M +42.9% −$5.0M n/m −$0.05 n/m -59.5% +95.3 pp $121M
UPBUpstream Bio, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$41.0M n/m −$0.75 n/m — — $115M
INOInovio Pharmaceuticals, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$49.0M n/m −$0.50 n/m — — $113M
XGNExagen Inc. Healthcare Nov 10 Sep '26 $18.0M +5.9% −$6.0M n/m −$0.25 n/m -23.9% −6.0 pp $96M
STXSStereotaxis, Inc. Healthcare Nov 10 Sep '26 $9.0M +28.6% −$6.0M n/m −$0.07 n/m -72.5% +15.3 pp $88M
CPIXCumberland Pharmaceuticals Inc. Healthcare Nov 10 Sep '26 $2.0M n/m $78.0M n/m $5.07 n/m -89.8% — $87M
BDTXBlack Diamond Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$10.0M n/m −$0.17 n/m — — $83M
SEERSeer, Inc. Healthcare Nov 10 Sep '26 $4.0M 0.0% −$14.0M n/m −$0.25 n/m -368.4% +119.0 pp $81M
COYACoya Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M −100.0% −$11.0M n/m −$0.45 n/m — — $71M
GOSSGossamer Bio, Inc. Healthcare Nov 10 Sep '26 $38.0M +192.3% −$48.0M n/m −$7.36 n/m 18.7% +388.2 pp $68M
ATRAAtara Biotherapeutics, Inc. Healthcare Nov 10 Sep '26 $1.0M −66.7% −$2.0M n/m −$0.15 n/m -242.7% −139.2 pp $66M
PMVPPMV Pharmaceuticals, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$34.0M n/m −$0.52 n/m — — $65M
CRBPCorbus Pharmaceuticals Holdings, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$38.0M n/m −$1.81 n/m — — $62M
LNSRLENSAR, Inc. Healthcare Nov 10 Sep '26 $14.0M 0.0% −$5.0M n/m −$0.38 n/m -10.1% +42.8 pp $60M
BOLDBoundless Bio, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$5.0M n/m −$0.23 n/m — — $57M
XLOXilio Therapeutics, Inc. Healthcare Nov 10 Sep '26 $10.0M −47.4% −$6.0M n/m −$0.30 n/m -117.7% −107.6 pp $53M
IBIOiBio, Inc. Healthcare Nov 10 Sep '26 $1.0M n/m −$8.0M n/m −$0.05 n/m -775.6% — $53M
GANXGain Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$3.0M n/m −$0.07 n/m — — $50M
MDAISpectral AI, Inc. Healthcare Nov 10 Sep '26 $3.0M −25.0% −$4.0M n/m −$0.11 n/m -138.9% −50.8 pp $43M
HBIOHarvard Bioscience, Inc. Healthcare Nov 10 Sep '26 $22.0M +4.8% −$3.0M n/m −$0.58 n/m -5.2% −6.1 pp $42M
BMEABiomea Fusion, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$6.0M n/m −$0.09 n/m — — $35M
TELATELA Bio, Inc. Healthcare Nov 10 Sep '26 $19.0M −9.5% −$9.0M n/m −$0.16 n/m -38.5% −1.9 pp $34M
PRPOPrecipio, Inc. Healthcare Nov 10 Sep '26 $7.0M +16.7% $0.0M n/m $0.00 n/m 0.0% +1.0 pp $34M
KLRSKalaris Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$11.0M n/m −$0.46 n/m — — $34M
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.